146 related articles for article (PubMed ID: 35093896)
1. Circulating Markers of Neutrophil Extracellular Traps (NETs) in Patients With Ovarian Tumors.
Dobilas A; Thalin C; Wallen H; Borgfeldt C
Anticancer Res; 2022 Feb; 42(2):965-971. PubMed ID: 35093896
[TBL] [Abstract][Full Text] [Related]
2. NETosis in Long-Term Type 1 Diabetes Mellitus and Its Link to Coronary Artery Disease.
Aukrust SG; Holte KB; Opstad TB; Seljeflot I; Berg TJ; Helseth R
Front Immunol; 2021; 12():799539. PubMed ID: 35069582
[TBL] [Abstract][Full Text] [Related]
3. Citrullinated histone H3 as a novel prognostic blood marker in patients with advanced cancer.
Thålin C; Lundström S; Seignez C; Daleskog M; Lundström A; Henriksson P; Helleday T; Phillipson M; Wallén H; Demers M
PLoS One; 2018; 13(1):e0191231. PubMed ID: 29324871
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil extracellular traps in patients with liver cirrhosis and hepatocellular carcinoma.
Zenlander R; Havervall S; Magnusson M; Engstrand J; Ågren A; Thålin C; Stål P
Sci Rep; 2021 Sep; 11(1):18025. PubMed ID: 34504150
[TBL] [Abstract][Full Text] [Related]
5. Quantification of NETs-associated markers by flow cytometry and serum assays in patients with thrombosis and sepsis.
Lee KH; Cavanaugh L; Leung H; Yan F; Ahmadi Z; Chong BH; Passam F
Int J Lab Hematol; 2018 Aug; 40(4):392-399. PubMed ID: 29520957
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil extracellular traps in ischemic stroke thrombi.
Laridan E; Denorme F; Desender L; François O; Andersson T; Deckmyn H; Vanhoorelbeke K; De Meyer SF
Ann Neurol; 2017 Aug; 82(2):223-232. PubMed ID: 28696508
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil Extracellular Traps Formation and Citrullinated Histones 3 Levels in Patients with Kawasaki Disease.
Hu J; Qian W; Wang T; Ling J; Shi Y
Iran J Immunol; 2023 Sep; 3(20):327-334. PubMed ID: 37551669
[TBL] [Abstract][Full Text] [Related]
8. The association between circulating neutrophil extracellular trap related biomarkers and retinal vein occlusion incidence: A case-control pilot study.
Wan W; Liu H; Long Y; Wan W; Li Q; Zhu W; Wu Y
Exp Eye Res; 2021 Sep; 210():108702. PubMed ID: 34270977
[TBL] [Abstract][Full Text] [Related]
9. Citrullinated histone H3, a biomarker for neutrophil extracellular trap formation, predicts the risk of mortality in patients with cancer.
Grilz E; Mauracher LM; Posch F; Königsbrügge O; Zöchbauer-Müller S; Marosi C; Lang I; Pabinger I; Ay C
Br J Haematol; 2019 Jul; 186(2):311-320. PubMed ID: 30968400
[TBL] [Abstract][Full Text] [Related]
10. Validation of an enzyme-linked immunosorbent assay for the quantification of citrullinated histone H3 as a marker for neutrophil extracellular traps in human plasma.
Thålin C; Daleskog M; Göransson SP; Schatzberg D; Lasselin J; Laska AC; Kallner A; Helleday T; Wallén H; Demers M
Immunol Res; 2017 Jun; 65(3):706-712. PubMed ID: 28161762
[TBL] [Abstract][Full Text] [Related]
11. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
Leandersson P; Åkesson A; Hedenfalk I; Malander S; Borgfeldt C
PLoS One; 2020; 15(10):e0240418. PubMed ID: 33075095
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil extracellular trap formation is an independent risk factor for occult cancer in patients presenting with venous thromboembolism.
Rosell A; Gautam G; Wannberg F; Ng H; Gry H; Vingbäck E; Lundström S; Mackman N; Wallén H; Westerlund E; Thålin C
J Thromb Haemost; 2023 Nov; 21(11):3166-3174. PubMed ID: 37479035
[TBL] [Abstract][Full Text] [Related]
13. HE4 can help discriminate women with malignant ovarian
tumors only if CA125 levels are elevated.
Pitta Dda R; Sarian LO; Campos EA; Andrade LL; Sallum LF; Bragança JF; Campos Cde M; Derchain S
Int J Biol Markers; 2013; 28(4):e377-86. PubMed ID: 23828407
[TBL] [Abstract][Full Text] [Related]
14. Differentiating stage 1 epithelial ovarian cancer from benign ovarian tumours using a combination of tumour markers HE4, CA125, and CEA and patient's age.
Kondalsamy-Chennakesavan S; Hackethal A; Bowtell D; ; Obermair A
Gynecol Oncol; 2013 Jun; 129(3):467-71. PubMed ID: 23500084
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil extracellular traps: A novel therapeutic target for intracranial hemorrhage.
Jin J; Zhao X; Li W; Wang F; Tian J; Wang N; Gao X; Zhang J; Wu J; Mang G; Ma R; Hu S
Thromb Res; 2022 Nov; 219():1-13. PubMed ID: 36084517
[TBL] [Abstract][Full Text] [Related]
16. Anti-Apolipoprotein A-1 IgG Influences Neutrophil Extracellular Trap Content at Distinct Regions of Human Carotid Plaques.
da Silva RF; Baptista D; Roth A; Miteva K; Burger F; Vuilleumier N; Carbone F; Montecucco F; Mach F; Brandt KJ
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33086507
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil extracellular traps formation may be involved in the association of propranolol with the development of portal vein thrombosis.
Xu X; Xu S; Zhang Y; Wang L; Yan C; Xu Z; Zhao Q; Qi X
Thromb Res; 2024 Jun; 238():208-221. PubMed ID: 38733693
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of peripheral blood neutrophil extracellular traps in the diagnosis and progression of malignant tumors.
Wang M; Lv X; Wang Y; Li Y; Li H; Shen Z; Zhao L
Cancer Med; 2024 Feb; 13(3):e6935. PubMed ID: 38230764
[TBL] [Abstract][Full Text] [Related]
19. Symptoms, CA125 and HE4 for the preoperative prediction of ovarian malignancy in Brazilian women with ovarian masses.
Pitta Dda R; Sarian LO; Barreta A; Campos EA; Andrade LL; Fachini AM; Campbell LM; Derchain S
BMC Cancer; 2013 Sep; 13():423. PubMed ID: 24044637
[TBL] [Abstract][Full Text] [Related]
20. The impact of neutrophil extracellular traps on deep venous thrombosis in patients with traumatic fractures.
Liu L; Zhang W; Su Y; Chen Y; Cao X; Wu J
Clin Chim Acta; 2021 Aug; 519():231-238. PubMed ID: 34015302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
